Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice

Fig. 3

Effects of SCP on the mRNA expressions of lipogenic and cholesterol-related synthetic enzymes. a mRNA expressions of lipogenic enzymes (LXRα, SREBP-1c, FAS, and ACC) in the liver of mice were suppressed by SCP (100 mg/kg/day); b mRNA expressions of cholesterol-related synthetic enzymes (SREBP-2 and HMGCR) in the liver was suppressed by SCP-100 mg/kg/day. All data are expressed as mean (± SD) (n = 10) from three independent experiments; Between-group differences were assessed using one-way ANOVA with post hoc test. ** P < 0.01, * P < 0.05 vs. CON and CON + SCP groups; ## P < 0.01, # P < 0.05 vs. model group. SCP, Schisandra polysaccharide; NAFLD, non-alcoholic fatty liver disease; SD, standard deviation; ANOVA, analysis of variance

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X